Neuroinflammation - An early event in both the history and pathogenesis of Alzheimer's disease

Neurodegenerative Diseases

Volumn 7, Issue 1-3, 2010, Pages 38-41

  Eikelenboom, Piet ^a,b,c   Van Exel, Erik ^b   Hoozemans, Jeroen J M ^b   Veerhuis, Rob ^b   Rozemuller, Annemieke J M ^b   Van Gool, Willem A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Valeriuskliniek ^*  (Netherlands)

Author keywords

Amyloid; Acute phase reactants; Alzheimer's disease; Cytokines; Inflammaging; Innate immunity; Microglia

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AUTOPSY; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENCEPHALITIS; FAMILY HISTORY; GENETIC MARKER; HUMAN; MACROPHAGE ACTIVATION; MICROGLIA; NEOCORTEX; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ENCEPHALITIS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MODELS, BIOLOGICAL; NEOCORTEX;

EID: 76549104226     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000283480     Document Type: Conference Paper

References (19)

1. Fischer O: Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatsschr Psychiatr Neurol 1907; 22: 361-372.
2. Fischer O: Die presbyofrene Demenz, deren anatomischen Grundlage und klinische Abgrenzung. Z Ges Neurol Psychiatr 1910; 3: 371-471.
3. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, van Gool WA, Hoozemans JJM: The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 2006; 113: 1685-1695. (Pubitemid 44657664)
4. Fassbender K, Walter S, Kühl S, Landmann R, Ishii K, Bertsch T, Stalder K, Muelhauser F, Liu Y, Ulmer AJ, Rivest T, Lentschat T, Gulbins E, Jucker M, Staufenbiel M, Brechtel K, Walter J, Multhaup G, Penke B, Adachi Y, Hartmann T, Beyreuther K: The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004; 18: 2003-2005.
5. Hoozemans JJM, Veerhuis R, Rozemuller JM, Eikelenboom P: Neuroinflammation and regeneration in early stages of Alzheimer's disease pathology. Int J Dev Neurosci 2006; 24: 157-165.
6. Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, Masliah E: Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer's disease. J Neuropathol Exp Neurol 2006; 65: 142-151.
7. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW: Incipient Alzheimer's disease: microarray correlation reveal major transcriptional and tumor supressor responses. Proc Natl Acad Sci USA 2004; 101: 2713-2718.
8. Parachikova A, Agadjanyan MG, Cribss DH, Blurton-Jones M, Perreau, Rogers J, Beach TG, Cotman CW: Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 2007; 28: 1821-1833.
9. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB: In vivo-measurement of activated microglia in dementia. Lancet 2001; 358: 461-467.
10. Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ: Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 2009; 72: 56-62.
11. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ: Early inflammation in dementia: a 25-years follow-up of the Honolulu- Asia Aging Study. Ann Neurol 2002; 52: 168-174.
12. Yaffe K, Lindquist K, Penninx BWH, Simsonsick EM, Pahor M, Krichchevsky S, Launer L, Kuller L, Rubin S, Harris T: Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61: 76-80.
13. Dik MG, Jonker G, Hack CE, Smit JH, Comijs HC, Eikelenboom P: Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005; 64: 1371-1377.
14. Porcellini E, Davis EJ, Chiappelli M, Ianni E, Di Stefano G, Forti P, Ravaglia G, Licastro F: Elevated plasma levels of α 1-antichymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target. Curr Pharm Des 2008; 14: 2659-2664.
15. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S: Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128: 92-105.
16. Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T, Tan J: Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 2008; 5: 51.
17. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RGJ, Boomsma DI: Heritabili estimates of the innate immunity: an extended twin study. Genes Immun 2005; 6: 167-170.
18. van Exel E, Eikelenboom P, Comijs H, Frohlich M, Smit JH, Stek ML, Scheltens P, Eefsting JE, Westendorp RGJ: Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer's disease. Arch Gen Psychiatry 2009;66:1263-1270.
19. Eikelenboom P, van Gool WA: Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm 2004; 113: 1685-1695.